Search
How a new CEO has been trying to position Editas to execute on the promise of CRISPR
Gilmore O’Neill is working to inject stability and focus at Editas as it aims to execute on both ex-vivo and in-vivo crispr gene therapies.
Aug 2, 2023
top of page
Search
Follow BiotechTV
Also look for unique social pages for BiotechTV U.
.png){kind=logo}
Sponsor Spotlight
10x Genomics delivers powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Cited in more than 10,000 research papers, our innovative single cell, spatial, and in situ technologies enable discoveries across oncology, immunology, neuroscience, and more.
Our talented, dedicated science professionals have a distinguished record of creating innovative instruments, reagents, and software that analyze biological systems at a resolution that matches the complexity of biology.
bottom of page